Motif Bio raises £2.7 million via share placing by Anna Smith | Mar 26, 2019 | News | 0 Motif Bio has announced that it has raised £2.7 million from a share placing, to provide additional working capital. Read More
Motif Bio’s antibiotic granted US priority review by Selina McKee | Aug 14, 2018 | News | 0 US regulators have accepted for review a targeted, Gram-positive investigational antibiotic developed by UK biopharma Motif Bio for the treatment of acute bacterial skin and skin structure infections (ABSSSI). Read More